Inflammatory Bowel Disease Orals OTH-12 Efficacy and safety of vedolizumab subcutaneous formulation for ulcerative colitis: results of the visible trial Free WJ Sandborn1, F Baert2, S Danese3, Z Krznarić4, G D’Haens5, T Kobayashi6, X Yao7, J Chen7, K Kisfalvi7, S Vermeire2 1University of California San Diego USA 2University Hospitals Leuven, Belgium 3Humanitas University, Milan, Italy 4Clinical Hospital Centre Zagreb, Croatia 5Academic Medical Centre, Amsterdam, Netherlands 6Kitasato...